UNSPSC 51422115: Fluocortin butyl

This classification denotes a dermatologic agent and glucocorticoid C26H35FO5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6N7OA9MO7O, chemically known as butyl 6.alpha.-fluoro-11.beta.-hydroxy-16.alpha.-methyl-3,20-dioxopregna-1,4-dien-21-oate, but more generally known as fluocortin butyl, which bears US NIH Compound Identifier 15942715. European Medicines Agency schedules Fluocortin butyl in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB13900MIG.

Most nations, for tariff and trade purposes, schedule fluocortin butyl under HS 29372200 and SITC 54153. As of Q4 2014, FLUOCORTIN BUTYL remains US FDA's Preferred Term for this commodity. SMILES: CCCCOC(=O)C(=O)[C@H]1[C@@H](C[C@@H]2[C@@]1(C[C@@H]([C@H]3[C@H]2C[C@@H](C4=CC(=O)C=C[C@]34C)F)O)C)C.

UNSPSC 51422115 Fluocortin butyl is a Commodity code that in recent state and local procurement activity shows no alignment with its nominal pharmaceutical scope. The single recent opportunity tagged under this code—Seminole County, Florida's IFB60459723LAS—solicits naloxone and drug deactivation systems for community health support, not fluocortin butyl or any topical corticosteroid product. The mismatch suggests either a data-entry error in the county's procurement tagging or a broader misclassification issue within the opportunities database. State and local health departments and county health agencies are the typical issuing bodies for pharmaceutical and medical-supply procurement, but the available record does not provide a clear signal of actual procurement demand under this code.

The single recorded opportunity is Seminole County, Florida's IFB posted June 30, 2026, with a response deadline of July 26, 2023 (a date inconsistency in the source material itself). The county seeks 1,900 units of naloxone and 800 drug deactivation systems annually, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. Vendors must submit bids electronically, include all shipping and delivery costs, maintain workers' compensation and commercial general liability insurance, comply with E-Verify requirements, and accept a three-month probationary termination clause. No explicit set-aside or disadvantaged-enterprise designations apply. The code shows minimal to no recent relevant activity for fluocortin butyl procurement across state and local buyers and warrants further investigation into the classification accuracy before resource commitment.